Literature DB >> 25256191

Association study of MICA gene polymorphisms with rheumatoid arthritis susceptibility in south Tunisian population.

Y Achour1, A Kammoun, M Ben Hamad, N Mahfoudh, S Chaabane, S Marzouk, L Keskes, L Gaddour, Z Bahloul, A Maalej.   

Abstract

The aim of this study was to investigate the role of major histocompatibility complex (MHC) class I chain-related gene A (MICA) polymorphisms, important in natural killer (NK) cell function, in patients with rheumatoid arthritis (RA). A transmembrane (TM) alanine-encoding GCT repeats, termed A4, A5, A5.1, A6 and A9 in the MICA gene, and single-nucleotide polymorphisms (SNPs): the Met129Val polymorphism (rs1051792) and the nonsynonymously coding SNP (rs1051794) were genotyped in 142 patients with RA and 123 unrelated healthy individuals using, respectively, PCR fluorescent method, nested PCR-RFLP and allele specific PCR (ASP). Association was assessed based on the χ2 test, genotype relative risk (GRR) and odds ratio (OR) with 95% confidence intervals (CIs). Our results show a trend of association of the different MICA genotypes G/G, G/A and A/A (P = 0.029) which did not attain the significance after Bonferroni's correction (pc = 0.08). Although, we revealed a significant association of the genotype A/A of MICA-250 in patients with RA compared to healthy controls (pc = 0.033). In contrast, no significant differences between alleles and genotypes frequencies were found either with MICA-TM or MICA met129 val (P > 0.05) in our sample. Moreover, stratification of patients with RA according to clinical and immunological data for the different polymorphisms studied shows a significant association of both MICA-250 G allele (pc = 0.0075) and MICA-250 GG genotype (pc = 0.008) and both allelic (val) (pc = 0.021) and genotypic (val/val) distribution (pc = 0.0095) for MICA met129 val in the RF-positive subgroup compared to RF-negative patients with RA. In contrast, we found a strong association of the MICA-TM A9 allele in RF-negative patients with RA (pc = 0.0003). This study indicates the involvement of the MICA-250 polymorphism in the genetic susceptibility and severity to RA and suggests that variations in MICA-TM and MICA met129 val may have an effect on RA severity in our south Tunisian sample.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25256191     DOI: 10.1111/iji.12146

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  6 in total

1.  Association of NKG2D gene variants with susceptibility and severity of rheumatoid arthritis.

Authors:  C M Mariaselvam; R Tamouza; R Krishnamoorthy; D Charron; D P Misra; V K Jain; V S Negi
Journal:  Clin Exp Immunol       Date:  2016-12-18       Impact factor: 4.330

2.  A genetic variant in the placenta-derived MHC class I chain-related gene A increases the risk of preterm birth in a Chinese population.

Authors:  Junjiao Song; Jing Li; Han Liu; Yuexin Gan; Yang Sun; Min Yu; Yongjun Zhang; Fei Luo; Ying Tian; Weiye Wang; Jun Zhang; Julian Little; Haidong Cheng; Dan Chen
Journal:  Hum Genet       Date:  2017-09-01       Impact factor: 4.132

3.  MHC Class I Chain-Related Gene A Polymorphisms and Linkage Disequilibrium with HLA-B and HLA-C Alleles in Ocular Toxoplasmosis.

Authors:  Christiane Maria Ayo; Ana Vitória da Silveira Camargo; Fábio Batista Frederico; Rubens Camargo Siqueira; Mariana Previato; Fernando Henrique Antunes Murata; Aparecida Perpétuo Silveira-Carvalho; Amanda Pires Barbosa; Cinara de Cássia Brandão de Mattos; Luiz Carlos de Mattos
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

Review 4.  Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.

Authors:  Antje Isernhagen; Dörthe Malzahn; Heike Bickeböller; Ralf Dressel
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

5.  Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis.

Authors:  Milena Iwaszko; Jerzy Świerkot; Marta Dratwa; Barbara Wysoczańska; Lucyna Korman; Bartosz Bugaj; Katarzyna Kolossa; Sławomir Jeka; Piotr Wiland; Katarzyna Bogunia-Kubik
Journal:  Pharmacogenomics J       Date:  2020-03-03       Impact factor: 3.550

6.  Deciphering the Potential Pharmaceutical Mechanism of Chinese Traditional Medicine (Gui-Zhi-Shao-Yao-Zhi-Mu) on Rheumatoid Arthritis.

Authors:  Lin Huang; Qi Lv; Duoli Xie; Tieliu Shi; Chengping Wen
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.